"The highly qualified physicians and staff at Pacific Cancer Care work diligently to provide our patients & family members with a comfortable and caring environment while delivering high quality personalized care. Everything we do at PCC is designed with our patients' in mind."

During the past decade, Pacific Cancer Care conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 16 clinical trials were completed, i.e. on average, 64% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Cancer Care" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Oncotherapeutics" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Blood Cancer Research Partnership" with 2 trials as a collaborator, "The Leukemia and Lymphoma Society" with 2 trials as a collaborator and "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Cancer Care" are "Multiple Myeloma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Pacific Cancer Care" in a lesser frequency.

Most popular intervention types in "Pacific Cancer Care" are "Drug" (39 trials), "Other" (8 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (6 trials), "Abemaciclib" (4 trials), "Dexamethasone" (4 trials), "Nivolumab" (4 trials) and "Palbociclib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Cancer Care" are 39 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Cancer Care". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Pacific Cancer Care, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Cancer Care, 9 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".